Catena Biosciences

company

About

Biotech company focused on protein conjugation.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$5M
Industries
Biotechnology,Life Science
Founded date
Nov 17, 2020
Number Of Employee
1 - 10
Operating Status
Active

Catena Biosciences is a biotech startup based on research from the Francis and Doudna labs at UC Berkeley focusing on the treatment and cure of autoimmune disorders. Catena’s platform differentiates on the ability to fuse proteins together using enzyme activation of native amino acids to create new treatments in oncology, autoimmune disorders and vaccine development!

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$5M
Catena Biosciences has raised a total of $5M in funding over 2 rounds. Their latest funding was raised on Aug 1, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 1, 2021 Seed $5M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Catena Biosciences is funded by 1 investors. Gaingels are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Seed